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Letters to the EditorENDOCARDITIS SURGERY:
NEED FOR A SPECIFIC RISK
SCORING SYSTEM
To the Editor:
The study by Gaca and colleagues,1
reporting on the outcomes of infective
endocarditis (IE) surgery in a selected
portion of the Society of Thoracic Sur-
geons (STS) database population, de-
serves to be praised for representing
the first attempt in the literature to de-
velop a system for operative risk as-
sessment specific for endocarditis.
The need for a dedicated stratifica-
tion tool, useful both in preoperative
patient information and in bedside
decision-making processes, arises
from the peculiarities of IE surgery
compared with general cardiac sur-
gery: Postoperative outcomes may be
influenced not only by cardiovascular
anatomic and functional issues but
also by systemic infective and micro-
biological factors. One fundamental
variable affecting surgical outcome
is whether a native or prosthetic valve
is involved,2 mostly because of the
differential preoperative risk profiles
between these 2 distinct diseases.3 It
is unfortunate that the STS database
does not distinguish between native
and prosthetic IE; thus, this variable
was not considered when developing
the proposed score system.1 Other
factors pertaining to the infectious
process, including the anatomic pic-
ture (presence/absence of vegetations,
perivalvular abscess, or mycotic aneu-
rysms) and the microbiological cause,
are demonstrated to independently
predict outcomes.4 In addition, these
factors were lacking in the regression
models of the Duke study.1
Consequently, the proposed risk
score systems were formed by 13
and 14 risk factors for mortality and
composite end point, respectively,
that are generic; ‘‘active endocarditis’’
was the sole specific variable in-
cluded. Indeed, Gaca and colleagues’
system1 results in being a simplifica-
tion of the ‘‘valvular’’ STS score sys-
tem and substantially differs from theThe JournalEuropean System for Cardiac Opera-
tive Risk Evaluation, the other most
widely used tool, for only 3 factors,
but not specific for infective valve
disease. Both the authors’ score,1 al-
though with a C-statistic indicating
modest discriminating power, and
the European System for Cardiac Op-
erative Risk Evaluation, as recently
reported by others,5 consistently dem-
onstrated satisfactory performances in
IE prognostic stratification.
We are currently at work on a spe-
cific system for preoperative prognos-
tic stratification of native valve IE,
accounting, in multivariable analyses,
also for infective and anatomic vari-
ables. Our preliminary studies (M.
De Feo, MD, PhD, unpublished data,
2011) yielded a score system in which
critical preoperative hemodynamic
condition and renal failure were
among the most important predictors
of death. As Gaca and coworkers1 out-
lined, this is consistent with other ge-
neric cardiac surgery risk models.
However, 2 of the 6 risk factors ulti-
mately constituting our score system
were specific for the IE setting, that is,
perivalvular involvement and positivity
of the last preoperative blood culture
(that indicates unsuccessful or incom-
plete antibiotic therapy), a variable
significantly associated, in bivariate
analysis, with positive valve culture,
staphylococcal cause, emergency oper-
ation, and large vegetations.
The authoritativeness of the
authors’ institution in this field is
undoubted, and their previous contri-
butions to the knowledge on endocar-
ditis have set the benchmark for us all
in the daily clinical approach to this
high-risk disease. However, compared
with the importance and timeliness of
the study purpose, the limitations
affecting the regression models under-
lying Gaca and colleagues’ score1
constituted an important flaw.
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PERICARDIAL EFFUSION
To the Editor:
We read with interest the article by
Inan and colleagues.1 They have come
up with a good double-blind study on
a poorly studied but potentially lethal
complication after cardiac surgery.
They state that postoperative pericar-
dial effusion is multifactorial; how-
ever, they have come up with one
magic bullet for all the factors. They
also fail to tell us the nature of the
drained fluid. They had a significant
number of patients with mechanical
aortic valves whowere treated by anti-
coagulation and are expected to havery c Volume 142, Number 3 721
